Abstract:Humoral hypercalcemia of malignancy (HHM) is a paraneoplastic syndrome caused by elevations in parathyroid hormone-related protein (PTH-rP). HHM often presents in patients with squamous cell carcinomas of the lung, head, and neck, as well as breast, ovarian, renal, and bladder carcinomas. HHM associated with neuroendocrine carcinoma (NEC) is rarely observed. Here, we report a case of NEC-associated HHM refractory to standard calcium-reducing therapies but improved with the off-label addition of cinacalcet. A 31-year-old male with metastatic NEC presented to the emergency department (ED) with symptoms of nausea, emesis, constipation, and progressive weakness. He was being treated via a clinical trial at a tertiary referral center after failing standard therapies. He had recently been admitted at an outside facility for hypercalcemia, which had been managed with denosumab (120 mg subcutaneously) over the previous four weeks. He was admitted from the ED with a serum calcium of 14.6 mg/dL, potassium of 2.9 mmol/L, and phosphate of 1.2 mg/dL; ionized calcium was elevated at 8.0 mg/dL. Despite hydration and aggressive electrolyte replacement, his calcium increased to 15.5 mg/dL. Further laboratory evaluation revealed parathyroid hormone (PTH) of 6 pg/mL (10-65 pg/mL), 25-hydroxyvitamin D of 25 ng/mL (25-80 ng/mL), 1,25-dihydroxyvitamin D of 513 pg/mL (18-64 pg/mL), and PTH-rP of 25 pmol/L (<2.5 pmol/L), consistent with HHM. Calcitonin was avoided due to a prior hypersensitivity reaction. He received prednisone 10 mg daily and pamidronate 90 mg IV, and his calcium improved to 11.5 mg/dL. He was discharged and investigational therapy was resumed. This therapy failed, and he did not qualify for additional cancer therapy due to refractory hypercalcemia. He was started on cinacalcet, and his calcium decreased enough to permit further cancer treatment. He had multiple hospitalizations with fluctuating calcium levels and ultimately died several months later after sustaining a subarachnoid hemorrhage from a fall. In conclusion, we report a rare case of HHM associated with NEC. While many cases of HHM are effectively managed with hydration, calcitonin, antiresorptive therapies, and glucocorticoids, some are refractory. Our patient was refractory and differed from most patients with HHM in at least two ways. As mentioned previously, NEC causing HHM is quite uncommon (~2% of cases); it is unclear, but this malignancy might predispose to refractory hypercalcemia. Our patient's elevated vitamin D may also have made his HHM more resistant to treatment. Ultimately, while not first line, cinacalcet was an effective treatment in our patient. This provides additional evidence that cinacalcet may be considered for refractory hypercalcemia secondary to malignancy.

S2357 Necrotizing Pancreatitis Secondary to Hypercalcemia as Initial Presentation of Renal Cell Carcinoma

Hepatocellular Carcinoma Complicated with Huge Posterior Pancreas Head Lymph Node Metastasis and Primary Renal Carcinoma: A Case Report

S2419 Unanticipated Culprits: A Rare Case of Drug-Induced Acute Necrotizing Pancreatitis

Unveiling the hidden culprit: Parathyroid adenoma induced recurrent renal calculus and pancreatitis-A case report

Neuroendocrine Carcinoma as a Cause of Humoral Hypercalcemia of Malignancy: A Case of a Patient With Elevated Parathyroid Hormone-Related Protein

Acute necrotizing pancreatitis caused by ampullary cancer: a case report

Management of infected pancreatic necrosis in the setting of concomitant rectal cancer: A case report and review of literature

S153 Risk of Venous Thromboembolism in Acute Necrotizing Pancreatitis: A Propensity-Matched Analysis From a Multicenter US Cohort Study

Pancreatitis with Intraabdominal Venous Thrombosis as an Initial Presentation of Parathyroid Adenoma: A Rare Clinical Presentation

S2379 Acute Pancreatitis Secondary to Metastatic Breast Cancer to the Pancreas

S2685 Unmasking The Pancreatic Phantom

S2526 A Case of Chronic Pancreatitis due to Primary Hyperparathyroidism and the Barriers to Definitive Treatment

Bilateral renal cortical necrosis following acute pancreatitis - A rare complication of a common disease

S2527 Necrotizing Pancreatitis With Gastric and Colonic Fistulae

Necrotizing pancreatitis: diagnosis, imaging, and intervention

Malignant Hypertension Complicated with Necrotizing Pancreatitis After Starting Treatment: A Case Report

Clinical predictors of pancreatic carcinoma causing acute pancreatitis

Atypical Presentation of Primary Hyperparathyroidism as Recurrent Pancreatitis: A Case Report With a Review of the Literature

Clinical characteristics and outcome of tumor-associated acute pancreatitis: a single-center cohort study

A Rare Case of Rapidly Transforming Pancreatitis With Life-Threatening Complications and Multi-Organ Failure

Calcitriol Unleashed: A Rare Culprit in Hypercalcemia Associated With Rare Primary Pancreatic Lymphoma - A Case Report